Parkinson’s Disease (PD) is a progressive neurodegenerative disease that affects movement. More than 10 million people around the world are living with Parkinson’s. Over 60,000 new diagnoses are made each year in the United States.
There is no Parkinson’s cure in sight and symptoms gradually worsen with time. While tremors are the most widely recognized Parkinson’s symptom, stiffness, and slowing of movement are also common. Although there are a number of medications that can allay symptoms, there are no effective preventive or curative measures for PD at this time. Gene therapy and cell therapy are two promising routes.
Integrated Health System’s gene therapy targeting neurodegeneration utilizes an adeno-associated virus (AAV) vector platform modified for the enhanced delivery to neural tissue. The genes to treat the disorder are inserted into the delivery method, which then delivers the genes of interest to the patient’s cells. In recent years, AAV gene therapies have been tested in humans with great success, and no evidence of adverse effects has been visible. There are numerous clinical trials currently being conducted with AAV gene therapy for many diseases. This is why telomerase shows promise for Alzheimer’s and Parkinson’s.
Our technology and care, your healthy longevity:
IHS is dedicated to providing you with the latest breakthroughs in medical technologies to help you at this difficult time in your life. Our doctors are here to help you every step of the way. To schedule your 20 minutes consultation with a doctor from Integrated Health Systems, please click
Chinta, Shankar J., et al. “Cellular senescence and the aging brain.” Experimental gerontology 68 (2015): 3-7
Daria et al. “Young microglia restore amyloid plaque clearance of aged microglia”. The EMBO Journal. (2016)
Flanary, Barry E., et al. “Evidence that aging and amyloid promote microglial cell senescence.” Rejuvenation research 10.1 (2007): 61-74
Haendeler, Judith, et al. “Mitochondrial telomerase reverse transcriptase binds to and protects mitochondrial DNA and function from damage.” Arteriosclerosis, thrombosis, and vascular biology 29.6 (2009): 929-935
Kronenberg, Golo, et al. “Repression of telomere-associated genes by microglia activation in neuropsychiatric disease.” European Archives of Psychiatry and Clinical Neuroscience (2016): 1-5.
Salminen, Antero, et al. “Astrocytes in the aging brain express characteristics of senescence‐associated secretory phenotype.” European Journal of Neuroscience 34.1 (2011): 3-11
Silva, Patricia Natalia Oliveira, et al. “Promoter methylation analysis of SIRT3, SMARCA5, HTERT and CDH1 genes in aging and Alzheimer’s disease.” Journal of Alzheimer’s Disease 13.2 (2008): 173-176